Lilly stock was up 4.8% at $969.14, putting it on pace for a record closing high, according to Dow Jones Market Data. The ...

MeiraGTx’s AAV-AIPL1 has already led to vision gains in blind children, as regulatory submissions for the gene therapy close ...

A man who fainted in the Oval Office last week was a patient of a weight-loss drug company, according to reports.

Choose Boston Business Journal as a preferred news source to see more of our reporting on Google. The deal could mean over ...

() -MeiraGTx Holdings has signed a deal with Eli Lilly, potentially worth over $475 million,​ granting the pharma giant ...

Market Catalysts host Julie Hyman tracks several of the day's top trending stock tickers, including Plug Power (PLUG) ...

MeiraGTx (MGTX) shares added ~18% in the premarket on Monday after the genetic medicines company announced a broad strategic ...

Healthcare investors think OpenAI could build a personal health assistant complete with medical records, a project that's ...

CMS's Abe Sutton said GENEROUS aims to ensure that Medicaid pricing will be on par with that in other developed nations.

Shares of Metsera fell over 15% in premarket trading on Monday, after the weight-loss drug developer accepted a sweetened ...

Eli Lilly shares are rising Monday after Leerink Partners upgraded the stock to Outperform and raised its price target to ...

For long-term investors, there are plenty of reasons to buy and hold Eli Lilly for not only years but decades.